Vanderbilt's James E. Crowe, Jr, MD, and Neil Osheroff, PhD, are among 12 individuals honored by the Association of American Medical Colleges during its 2023 Awards Recognition Event.

The All of Us Engagement Core at Vanderbilt University Medical Center is helping make human research more welcoming to accelerate the prevention and treatment of illness through genomic and precision medicine.

An artificial intelligence tool developed at Vanderbilt accurately identified pediatric patients at high risk for blood clots in a clinical trial, with no difference in outcomes compared to a control group.

Biostatisticians at VUMC have played a pivotal role in the redesign of clinical trials that rigorously and rapidly determine the effectiveness of life-saving treatments for acutely ill patients.

Vanderbilt researchers report that when people who are having their brains scanned by fMRI perform a task, like wiggling their fingers, certain signals increase in white matter throughout the brain, which has long been thought to play a lesser role the more the brain's more energetic gray matter.

A research paper co-authored by 23 high school and undergraduate students participating in Vanderbilt University Medical Center’s Aspirnaut summer research program has been selected as one of the “Editor’s Picks” by the Journal of Biological Chemistry.